8-K - Lixte Biotechnology Holdings, Inc. | StockGist

Current Report Details

Event Type

Management Change

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. (b) Effective

Management Change

$150.0KChairman of the Company’s Scientific Advisory CoPresident of the Company (but remains as the CompCompany on any matter relating to the Company

8.01

Other Events On September 3, 2025, the Company issued a press release regarding the appointment of two new Board Members and a new Chief Financial Officer. A co

Other Event

9.01

Financial Statements and Exhibits (b) There is filed as part of this report the exhibits listed on the accompanying index to exhibits. SIGNATURES Pursuant to th

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1